Global Companion Diagnostics Market 2018-2024 by Technology, Applications, End-Users, and Regions - ResearchAndMarkets.com

DUBLIN--()--The "Global Companion Diagnostics Market - Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018-2024" report has been added to ResearchAndMarkets.com's offering.

The Global Companion Diagnostics market is estimated to witness a CAGR of 19.6% during the forecast period 2018-2024. The market is analyzed based on four segments - technology, applications, end-users, and regions.

The companion diagnostics market is booming due to increasing patient base for infectious diseases & cancer globally, high adoption of companion diagnostics, growing demand for companion diagnostics, and emerging applications of companion diagnostics. Low awareness & lack of professionals to conduct tests and unfavorable reimbursement scenario in developed & developing countries are few of the factors hampering the market growth to an extent.

The global companion diagnostics market, by technology, is segmented into polymerase chain reaction, immunohistochemistry, in-situ hybridization, next-generation sequencing, and others. Polymerase chain reaction occupied the largest share in 2017, and next-generation sequencing is expected to grow at a high CAGR in the coming years.

Market Dynamics

Drivers

  • Growing incidence of cancer across the globe
  • Rising adoption of companion diagnostics tests
  • Growing demand of personalized medicine

Opportunities

  • Emerging applications of companion diagnostics
  • Growing demand for next-generation sequencing

Restraints

  • Uncertain reimbursement scenario in developed and developing countries
  • Lack of professionals to perform the test

Key Topics Covered:

1. Industry Outlook

2. Report Outline

3. Market Snapshot

4. Market Outlook

5. Market Characteristics

6. Technology: Market Size and Analysis

7. Application: Market Size and Analysis

8. End Users: Market Size and Analysis

9. Regions: Market Size and Analysis

10. Competitive Landscape

11. Vendor Profiles

  • F. Hoffmann-La Roche Ltd
  • Qiagen N.V.
  • Abbott Laboratories
  • Myriad Genetics
  • Agilent Technologies Inc.
  • BioMerieux S.A.
  • Danaher Corporation (Leica Microsystems AG)
  • Resonance Health Limted
  • Thermo Fisher Scientific Inc.
  • Genomic Health

For more information about this report visit https://www.researchandmarkets.com/research/36rfb4/global_companion?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics